We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$11.7B
AUM Growth
+$657M
Cap. Flow
+$823M
Cap. Flow %
7.02%
Top 10 Hldgs %
29.51%
Holding
1,637
New
161
Increased
846
Reduced
407
Closed
144

Sector Composition

Rank Sector Weight
1 Technology 12.36%
2 Healthcare 8.23%
3 Financials 6.88%
4 Consumer Discretionary 6.01%
5 Consumer Staples 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUZ icon
976
Cousins Properties
CUZ
$4.88B
$655K 0.01%
26,474
+6,528
+33% +$159K
HELE icon
977
Helen of Troy
HELE
$693M
$651K 0.01%
7,008
+761
+12% +$74.1K
CWEN icon
978
Clearway Energy Class C
CWEN
$6.7B
$650K 0.01%
20,410
+2
+0% +$67
TPR icon
979
Tapestry
TPR
$32.8B
$650K 0.01%
20,330
+465
+2% +$15.9K
UTHR icon
980
United Therapeutics
UTHR
$23.1B
$650K 0.01%
2,958
+1,480
+100% +$374K
VOE icon
981
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
$648K 0.01%
5,556
+42
+0.8% +$5.63K
EXPE icon
982
Expedia Group
EXPE
$37.3B
$648K 0.01%
6,696
+629
+10% +$59.5K
ENS icon
983
EnerSys
ENS
$6.99B
$648K 0.01%
8,769
-6,468
-42% -$452K
AXSM icon
984
Axsome Therapeutics
AXSM
$10.9B
$647K 0.01%
+5,200
New +$311K
PEN icon
985
Penumbra
PEN
$12.8B
$645K 0.01%
3,566
+2,503
+235% +$489K
MDRX
986
DELISTED
Veradigm Inc. Common Stock
MDRX
$644K 0.01%
42,526
-8,727
-17% -$146K
NGVT icon
987
Ingevity
NGVT
$2.68B
$643K 0.01%
9,139
-5,320
-37% -$375K
FE icon
988
FirstEnergy
FE
$27.5B
$638K 0.01%
22,046
+11,911
+118% +$466K
AGNC icon
989
AGNC Investment
AGNC
$12.9B
$638K 0.01%
61,930
-144,646
-70% -$1.32M
PBE icon
990
Invesco Biotechnology & Genome ETF
PBE
$353M
$635K 0.01%
10,000
GMED icon
991
Globus Medical
GMED
$11.2B
$635K 0.01%
23,082
+1,876
+9% +$128K
OVV icon
992
Ovintiv
OVV
$16.4B
$635K 0.01%
12,516
-36
-0.3% -$1.88K
AAWW
993
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$632K 0.01%
6,266
-186
-3% -$18.6K
TEVA icon
994
Teva Pharmaceuticals
TEVA
$41.2B
$632K 0.01%
11,780
-8,474
-42% -$73.9K
DQ
995
Daqo New Energy
DQ
$996M
$630K 0.01%
16,322
-82
-0.5% -$4.01K
VTR icon
996
Ventas
VTR
$47.9B
$626K 0.01%
23,740
-2,916
-11% -$123K
CROX icon
997
Crocs
CROX
$6.55B
$620K 0.01%
7,192
+3,042
+73% +$269K
KSS icon
998
Kohl's
KSS
$2.19B
$619K 0.01%
26,206
-7,505
-22% -$213K
GPK icon
999
Graphic Packaging
GPK
$3.58B
$618K 0.01%
+19,390
New +$426K
PVH icon
1000
PVH
PVH
$4.04B
$614K 0.01%
10,524
+5,231
+99% +$312K

Similar funds

Pathstone Family Office's Q4 2022 Portfolio in Review

As of Q4 2022, Pathstone Family Office held 1,637 positions worth $11.7B, up 5.9% from $11.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Pathstone Family Office deployed $823M of net new capital in Q4 2022, opening 161 new positions and adding to 846 existing holdings. Its largest new stake was Dimensional US Large Cap Value ETF: 7,009,786 shares worth $172M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Morningstar Value ETF, an estimated $173M trimmed.

  • Pathstone Family Office's largest Q4 2022 buy was Dimensional US Large Cap Value ETF: 7,009,786 shares worth $172M.
  • Pathstone Family Office added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $70.2M increase.
  • Pathstone Family Office's biggest Q4 2022 reduction was Vanguard Morningstar Value ETF, cutting an estimated $173M.
  • Pathstone Family Office fully exited Invesco Senior Loan ETF in Q4 2022, selling an estimated $82.4M.
  • Pathstone Family Office's ten largest holdings make up 30% of its $11.7B portfolio in Q4 2022.
  • Pathstone Family Office opened 161 new positions and closed 144 in Q4 2022.
  • Pathstone Family Office's portfolio value rose 5.9% quarter-over-quarter to $11.7B.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.